The automated West Nile virus test conducted by Pleasanton’s Roche Molecular Systems Inc. has won U.S. Food and Drug Administration authorization
It is the second FDA sanctioned examination for identifying the virus in blood and organs.
San Diego’s Gen-Probe Inc. developed the initial test, which is marketed by Emeryville’s Novartis Vaccines and Diagnostics Inc., part of Novartis AG.